e-learning
resources
Munich 2006
Sunday 03.09.2006
Assessment in the chronic patient
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation
M. A. Spruit, A. M. W. J. Schols, J. Does, R. Lunde, H. J. Pennings, P. P. Janssen, E. F. M. Wouters (Horn, Maastricht, Netherlands)
Source:
Annual Congress 2006 - Assessment in the chronic patient
Session:
Assessment in the chronic patient
Session type:
E-Posters in free access
Number:
505
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Spruit, A. M. W. J. Schols, J. Does, R. Lunde, H. J. Pennings, P. P. Janssen, E. F. M. Wouters (Horn, Maastricht, Netherlands). Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation. Eur Respir J 2006; 28: Suppl. 50, 505
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Loss of bone mineral density in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007
A comparison of bone mineral density in elderly patients with COPD and bronchial asthma
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Changes in bone mineral density and fat-free mass following pulmonary rehabilitation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 607s
Year: 2006
Bone mineral density in patients with COPD depending on pulmonary function parameters
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Relationship between annual change of bone mineral density, emphysema and pulmonary function in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015
Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity?
Source: Eur Respir J 2005; 26: Suppl. 49, 526s
Year: 2005
Current status of research on osteoporosis in COPD: a systematic review
Source: Eur Respir J 2009; 34: 209-218
Year: 2009
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R)
Source: Eur Respir J 2002; 19: 1058-1063
Year: 2002
Changes in bone mineral density after lung volume reduction surgery for severe emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 607s
Year: 2002
Bone mineral density in patients with chronic respiratory failure listed for transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Bone mineral density is related to exercise capacity in COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
The bone metabolism in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002
Clinical impact of the relationship between low bone mineral density and peripheral muscle strength in patients with COPD
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012
Determinants of bone mineral density in the lumbar spine instable patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
The relationships between sarcopenia and decreased bone mineral density in each obstructive airway disease phenotype of Korea.
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept